Current Radiopharmaceuticals

Latest Articles

Meet Our Editorial Board Member

Volume 11 Issue 3

Author(s): Alan C. Spivey
Pages: 153-153 (1)
Free
The Evolving Clinical Role of Actinium-225 and Bismuth-213 for Targeted Alpha Therapy (TAT) - Production, Radiopharmaceutical Development and Clinical Applications

Volume 11 Issue 3

Author(s): Valery Radchenko, Paul Schaffer and F.F. (Russ) Knapp
Pages: 154-155 (2)
Free
Development of ²²⁵Ac Radiopharmaceuticals: TRIUMF Perspectives and Experiences

Volume 11 Issue 3

Author(s): Andrew Kyle Henderson Robertson, Caterina Fortunata Ramogida, Paul Schaffer and Valery Radchenko*
Pages: 156-172 (17)
Free
The Production of Ac-225

Volume 11 Issue 3

Author(s): Jonathan W. Engle*
Pages: 173-179 (7)
NorthStar Perspectives for Actinium-225 Production at Commercial Scale

Volume 11 Issue 3

Author(s): James T. Harvey*
Pages: 180-191 (12)
Clinical Studies with Bismuth-213 and Actinium-225 for Hematologic Malignancies

Volume 11 Issue 3

Author(s): Joseph G. Jurcic*
Pages: 192-199 (8)
An Overview of Targeted Alpha Therapy with ²²⁵Actinium and ²¹³Bismuth

Volume 11 Issue 3

Author(s): Alfred Morgenstern*, Christos Apostolidis, Clemens Kratochwil, Mike Sathekge, Leszek Krolicki and Frank Bruchertseifer
Pages: 200-208 (9)
Free
Dosimetry and Radiobiology of Alpha-Particle Emitting Radionuclides

Volume 11 Issue 3

Author(s): George Sgouros*, Robert Hobbs and Anders Josefsson
Pages: 209-214 (6)
In vivo Evaluation of Free and Chelated Accelerator-produced Actinium- 225 - Radiation Dosimetry and Toxicity Results

Volume 11 Issue 3

Author(s): Zewei Jiang, Ekaterina Revskaya, Darrell R. Fisher and Ekaterina Dadachova*
Pages: 215-222 (8)
In vivo Evaluation of [²²⁵Ac]Ac-DOTA^ZOL for α-Therapy of Bone Metastases

Volume 11 Issue 3

Author(s): Nina Pfannkuchen, Nicole Bausbacher, Stefanie Pektor, Matthias Miederer and Frank Rosch*
Pages: 223-230 (8)
Acknowledgement to Reviewers

Volume 11 Issue 3

Author(s):
Pages: 231-231 (1)
Free
Editor's Note

Volume 11 Issue 3

Author(s):
Pages: 232-232 (1)
Free

Endorsement(s)

Announcements

Related Journals

Anti-Cancer Agents in Medicinal Chemistry aims to cover all the latest and outstanding developments in medicinal chemistry and rational drug design for the discovery of anti-cancer agents.

The journal Anti-Inflammatory & Anti-Allergy Agents in Medicinal Chemistry publishes expert reviews, original research articles, drug clinical trial studies and special topic issues.

Current Computer-Aided Drug Design aims to publish all the latest developments in drug design based on computational techniques. The field of computer-aided drug design has had extensive impact in the area of drug design.

Current Cancer Drug Targets is high impact factor journal and essential reading for all pharmaceutical scientists involved in drug discovery and development.

Combinatorial Chemistry & High Throughput Screening is a high impact factor journal, having an impact factor 1.041, and is indexed by all major indexing agencies.

The journal Current Drug Safety publishes frontier articles on all the latest advances on drug safety.

The journal Current Clinical Pharmacology publishes frontier reviews on all the latest advances in clinical pharmacology.

Current Drug Targets is essential reading for all pharmaceutical scientists involved in drug discovery and development.

Current Drug Metabolism is an essential journal for academic, clinical, government and pharmaceutical scientists who wish to be kept informed and up-to-date with the latest and most important developments in this field.

Current Drug Delivery journal is essential reading for all pharmaceutical scientists involved in drug design, development and delivery.

Current Organic Chemistry is a high impact factor journal, having an impact factor 1.949, and is indexed by all major indexing agencies.

Cardiovascular & Hematological Agents in Medicinal Chemistry aims to cover all the latest and outstanding developments in medicinal chemistry and rational drug design for the discovery of new Cardiovascular & Hematological Agents.

Cardiovascular & Hematological Disorders-Drug is essential reading for all pharmaceutical scientists involved in drug discovery and development.

Current Molecular Medicine is a high impact factor journal, having an impact factor 3.621 and is indexed by all major indexing agencies.

Current Medicinal Chemistry covers all the latest and outstanding developments in medicinal chemistry and rational drug design.

Current Neuropharmacology is an impact factor journal and covers all areas of neuropharmacology and related matters of neuroscience.

Current Nanoscience is a high impact factor journal and is essential reading to all involved in nanoscience and its applied areas.

Current Gene Therapy is a bi-monthly peer-reviewed journal, aimed at academic and industrial scientists, with an interest in major topics concerning basic research and clinical applications of gene and cell therapy of genetic diseases.

Current Pharmaceutical Design covers all subject areas of major importance to modern drug design including: medicinal chemistry, pharmacology, drug targets and disease mechanism.

Current Pharmaceutical Biotechnology aims to cover all the latest and outstanding developments in Pharmaceutical Biotechnology.

The Current Neurovascular Research emphasizes the elucidation of disease mechanisms, both cellular and molecular, which can impact the development of unique therapeutic strategies for neuronal and vascular disorders.

Current Pharmaceutical Analysis provides convincing and state-of-the-art reviews and original research articles to Pharmaceutical and Biomedical scientists.

The journal Current Organic Synthesis aims to provide an informed and up to date review on topical areas of interest to synthesis chemists.

Central Nervous System Agents in Medicinal Chemistry aims to cover all the latest and outstanding developments in medicinal chemistry and rational drug design for the discovery of new central nervous system agents.

Current Topics in Medicinal Chemistry is essential reading for every medicinal chemist who wishes to be kept informed with the latest developments in medicinal chemistry and in other allied disciplines.

Current Vascular Pharmacology is a high impact factor journal, having an impact factor 2.374, and is indexed by all major indexing agencies.

Current Protein & Peptide Science is a high impact factor journal and is indexed by all major indexing agencies.

Mini-Reviews in Organic Chemistry is an impact factor journal, and reports original reviews in all areas of organic chemistry.

Recent Patents on Anti-Cancer Drug Discovery is essential reading for all researchers involved in anti-cancer drug design and discovery.

The journal Letters in Organic Chemistry is an essential reading for all organic chemists belonging to both academia and industry.

The journal Recent Patents on Anti-Infective Drug Discovery is essential reading for all researchers involved in anti-infective drug design and discovery.

Medicinal Chemistry is a peer-reviewed journal and aims to cover all the latest outstanding developments in medicinal chemistry and rational drug design.

Protein and Peptide Letters provides an excellent venue for communication of succinct reports of interesting research findings.

The journal Infectious Disorders - Drug Targets is essential reading for all pharmaceutical scientists involved in drug design, discovery and development.

Mini-Reviews in Medicinal Chemistry publishes short reviews on the important recent developments in medicinal chemistry and allied disciplines.

Letters in Drug Design & Discovery is essential reading for all pharmaceutical scientists involved in drug design and discovery.

The journal Endocrine, Metabolic & Immune Disorders-Drug Targets publishes timely reviews of experimental and clinical studies in the field of endocrine, metabolic, and immune disorders.

Current Stem Cell Research & Therapy is a high impact factor journal, and is essential reading for all researchers & clinicians involved in stem cells research.

The journal Recent Patents on CNS Drug Discovery is essential reading for all researchers involved in CNS drug design and discovery.

The journal Reviews on Recent Clinical Trials publishes frontier reviews, original research articles, drug clinical trial studies and guest edited thematic issues on recent clinical trials of major importance.

Current Alzheimer Research publishes peer-reviewed reviews, research, drug clinical trial studies and letter articles on all areas of Alzheimer’s disease.

Current HIV Research is a high impact factor journal and is essential reading for all the stakeholders involved in HIV research.

The journal Current Drug Discovery Technologies publishes comprehensive overviews of all the major modern techniques and technologies used in drug design and discovery.

CNS & Neurological Disorders - Drug Targets is a high impact factor journal and is essential reading for all pharmaceutical scientists involved in drug discovery and development.

Current Proteomics publishes well-timed review articles on topics relevant and significant to the development of proteomics.

The journal Drug Metabolism Letters is widely read journal in its field, and is indexed by all the major indexing agencies. This journal is essential reading for all the researchers involved in drug metabolism and disposition studies

The journal Recent Patents on Drug Delivery & Formulation is essential reading for all researchers involved in the fields of drug delivery and formulation

The journal Recent Patents on Nanotechnology is essential reading for all researchers involved in nanotechnology.

The journal Recent Patents on Endocrine, Metabolic & Immune Drug Discovery is essential reading for all researchers involved in endocrine, metabolic and immune drug design and discovery

The journal Recent Patents on Inflammation & Allergy Drug Discovery is essential reading for all researchers involved in inflammation and allergy drug design and discovery.

Current Drug Target -Infectious Disorders

The journal Current Drug Abuse is of interest to a broad audience in its field, and is indexed by all the major indexing agencies

The journal publishes expert reviews, original research articles and thematic issues on molecular pharmacology

The journal Current Aging Science is essential reading for researchers, educators and physicians with interest in aging, age-related dementia and Alzheimer’s disease and longevity.

The Natural Products Journal a peer reviewed journal aims to publish all the latest and outstanding developments in natural products.

The journal Pharmaceutical Nanotechnology is essential reading for all the researchers involved in pharmaceutical implications of the nanotechnology.

About the Publisher

Bentham Science: An Introduction

We have been serving the needs of STM field since 1992 and publish 117 titles, fulfilling the information needs for the Pharmaceutical and Biomedical research community. We are publishers of many high impact factor Journals and eBooks.

Subscription Information:

All Journals are available online. For information on the Journals and how to order, please visit our web site at: www.benthamscience.com/journal/price-order.php and select "Prices and Ordering" or contact our subscription department at: subscriptions@benthamscience.org

Open Access:

Bentham Science currently offers authors the choice of publishing their articles as open access. Please refer to the Journal instructions for authors for details.